Showing results (111-120 of 146) with videos related to

Sort By:
Pageof 15
The American Journal of Psychiatry|August 1, 1982
d-Amphetamine-induced heterogeneous changes in psychotic behavior in schizophreniaD P van Kammen, W E Bunney, J P Docherty, et al.
Novartis Foundation Symposium|May 24, 2008
The fibroblast growth factor family and mood disordersH Akil, S J Evans, C A Turner, et al.
The American Journal of Psychiatry|February 1, 1996
PET and MRI of the thalamus in never-medicated patients with schizophreniaM S Buchsbaum, T Someya, C Y Teng, et al.
Biological Psychiatry|February 1, 1979
CSF calcium: clinical correlates in affective illness and schizophreniaD C Jimerson, R M Post, J S Carman, et al.
Molecular Psychiatry|June 17, 2003
Novel truncated isoform of SK3 potassium channel is a potent dominant-negative regulator of SK currents: implications in schizophreniaH Tomita, V G Shakkottai, G A Gutman, et al.
Science (New York, N.Y.)|July 1, 1977
Intravenous naloxone administration in schizophrenia and affective illnessG C Davis, W E Bunney, E G DeFraites, et al.
Acta Psychiatrica Scandinavica|April 1, 1980
A collaborative study of genetic linkage of bipolar manic-depressive illness and red/green colorblindness. A project of the biological psychiatry collaborative program of the world health organizationE S Gershon, J Mendlewicz, M Gastpar, et al.
Psychiatry Research|August 1, 1982
Naloxone in chronic schizophrenic patients: neuroendocrine and behavioral effectsJ E Kleinman, D R Weinberger, A Rogol, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 16, 1997
Decreasing striatal 6-FDOPA uptake with increasing duration of cocaine withdrawalJ C Wu, K Bell, A Najafi, et al.
The American Journal of Psychiatry|November 1, 1981
Endogenous opioid activity and beta-endorphin immunoreactivity in CSF of psychiatric patients and normal volunteersD Naber, D Pickar, R M Post, et al.
Pageof 15